We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

99 hedge funds and large institutions have $35.6M invested in DermTech, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more capital invested

Capital invested by funds: $14.9M → $35.6M (+$20.7M)

46% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 13

20% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 20

5% more funds holding

Funds holding: 9499 (+5)

2% more call options, than puts

Call options by funds: $1.3M | Put options by funds: $1.27M

Holders
99
Holders Change
+5
Holders Change %
+5.32%
% of All Funds
1.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
24
Reduced
20
Closed
13
Calls
$1.3M
Puts
$1.27M
Net Calls
+$22K
Net Calls Change
-$179K

DMTK Hedge Fund Activity: Q1 2023 in Review

99 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2023, worth a combined $35.6M — up 139% from $14.9M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new DMTK positions and 13 closed out — a net gain of 6 holders — while 24 added to existing stakes and 20 trimmed.

The largest buyer was Bank of America, adding an estimated $4.02M. The largest seller was D.E. Shaw & Co, cutting an estimated $878K.

  • 99 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2023, up from 94 in Q4 2022.
  • Funds reported $35.6M of DermTech, Inc. Common Stock stock for Q1 2023, up 139% quarter-over-quarter.
  • 19 funds opened new DermTech, Inc. Common Stock positions in Q1 2023 and 13 closed out, a net change of +6 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q1 2023 was Bank of America, an estimated $4.02M added.
  • The largest DermTech, Inc. Common Stock seller in Q1 2023 was D.E. Shaw & Co, an estimated $878K sold.

Based on aggregated 13F filings for Q1 2023.